Arkolith/Insider Trading/NLTX/Form 4

Patel Priti

Chief Medical OfficerNeoleukin Therapeutics, Inc. (NLTX) · full profile →Form 4 · filed May 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 2, 2022Sell(S)6K$1.22$7K6K
Apr 30, 2022Option exercise(M)10K—$012K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 30, 2022Option exercise(M)10K—$010K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-026894) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML